Newsroom

Our latest developments

Orca Bio’s announcements and press releases

Orca Bio Presents Positive Data Reinforcing Clinical Profile of Orca-T and Orca-Q at 2023 Transplantation & Cellular Therapy Meetings of ASTCT and CIBMTR

View

Orca Bio to Present at the 41st Annual J.P. Morgan Healthcare Conference

View

Orca Bio Presents Encouraging Interim Clinical Data on Orca-Q in Haploidentical Allogeneic Hematopoietic Stem Cell Transplants at 64th ASH Annual Meeting

View

Orca Bio Presents Data Demonstrating its Lead Investigational High-Precision Cell Therapy Orca-T Significantly Improved Relapse-Free Survival at 64th Annual Meeting

View

Orca Bio to Present Four Abstracts at the 64th American Society of Hematology Annual Meeting, Including Updated Relapse-Free Survival Data with Orca-T and the First Clinical Data for Orca-Q

View

Orca Bio Expands Manufacturing Capabilities to Develop and Commercialize its Precision Cell Therapies

View

Orca Bio Announces the Precision-T Phase 3 Study is Open and Enrolling Patients at Transplant Centers Across the U.S.

View

Orca Bio to Present New Clinical Data on Orca-T at the European Hematology Association 2022 Congress

View

Orca Bio’s fact sheets

Orca Bio Corporate Overview

View

For media inquiries,

contact us at: